SPOTLIGHT: Glenmark clears hurdle for European product launch


Glenmark Pharmaceuticals got the UK's thumbs up for its manufacturing facility in Baddi, India, enabling it to launch creams and ointments in the European market. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.